~~<i id='A41B25908B'><strike id='A41B25908B'><tt id='A41B25908B'><pre id='A41B25908B'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

explore

leisure time

author：hotspot 2025-09-30 16:28:28 - browse：3

Damian Garde of STAT talks with Liisa Bayko of Evercore ISI and Jared Holz of Mizuho at STAT in NYC. — Damian Garde of STAT, left, talked with Liisa Bayko of Evercore ISI and Jared Holz of Mizuho about the GLP-1 weight loss market. Michelle C. Gevint for STAT

NEW YORK — Will the world actually soon spend $100 billion a year on the new obesity medicines?

Plenty of people in pharma and at the banks that invest in it seem to think so. Goldman Sachs, Barclays, BMO Capital Markets and Pfizer have all arrived at the glossy, cut-for-headline number for spending by around 2030.

Yet Jared Holz, a healthcare strategist at Mizuho, is skeptical.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The high cost of giving birth even with insurance
Next article： Gene therapy for Afghan refugees’ infant will be fully covered

focus

leisure time

focus

entertainment

knowledge

hotspot

JoshuaA.Bickel/APInJanuary2023,minutesafterDamarHamlin collapsed onthefieldfollowingatackle,mycellph

WSS

Dogs on Prozac: What pet anti

Gene therapy for Afghan refugees’ infant will be fully covered

Readout LOUD: Venture capital, Gilead, and more M&A

H5N1 bird flu virus started spreading in cows in Texas in December

AstraZeneca stays mum on Medicare drug pricing negotiations

Unique patient identifier: Experts argue the benefits, pitfalls

explore

leisure time

focus

Virginia high school admissions case could be legal follow

Diversity in clinical trials starts with building trust, experts say

United colonoscopy coverage change 'may cost lives,' doctors say

Bernie brings in new pharma CEOs to talk drug prices

United colonoscopy coverage change 'may cost lives,' doctors say

Cancer researcher Catriona Jamieson is sending tumors into space

Hollywood unions extend contract negotiations for actors

A protest over insulin prices is seen as a fight for life

Malaria cases in Florida and Texas: Here’s what you need to know

Updated Covid vaccine has 54% effectiveness, new study suggests

leisure time

Novo Holdings to buy drug manufacturer Catalent in $16.5B deal

Global cancer cases to surge 77% by 2050, WHO report says

Why Novartis is going to walk from its acquisition of MorphoSys

Novo Holdings to buy drug manufacturer Catalent in $16.5B deal

MassMutual is introducing free genetic testing for members

Dogs on Prozac: What pet anti

focus

entertainment

knowledge

hotspot